Polyphosphazenes for Biology and Medicine: Current Status and Future Prospects

Polyphosphazenes for Biomedical Applications

Volumn , Issue , 2008, Pages 1-13

  Andrianov, Alexander K ^a   Langer, Robert ^b  

^a Apogee Technology Inc   (United States)

^b Massachusetts Institute of Technology   (United States)

Author keywords

High throughput synthesis and polyphosphazene library construction; Monofunctional PEG synthesis; Polyphosphazenes in biology and medicine

Indexed keywords

EID: 84889385139     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470478882.ch1     Document Type: Chapter

References (36)

1. Langer, R., Tirrell, D.A. Designing materials for biology and medicine. Nature, 2004, 428(6982):487-492.
2. Andrianov, A.K. Polyphosphazenes as vaccine adjuvants. In M. Singh, Ed. Vaccine Adjuvants and Delivery Systems. Wiley, Hoboken, NJ, 2007, pp. 355-378.
3. Andrianov, A.K., Marin, A., Chen, J. Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]. Biomacromolecules, 2006, 7(1):394-399.
4. Andrianov, A.K., Marin, A., Roberts, B.E. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity. Biomacromolecules, 2005, 6(3):1375-1379.
5. Andrianov, A.K., Svirkin, Y.Y., LeGolvan, M.P. Synthesis and biologically relevant properties of polyphosphazene polyacids. Biomacromolecules, 2004, 5(5):1999-2006.
6. Mutwiri, G., Benjamin, P., Soita, H., Townsend, H., Yost, R., Roberts, B., Andrianov, A.K., Babiuk, L.A. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens. Vaccine, 2007, 25(7):1204-1213.
7. Payne, L.G., Jenkins, S.A., Andrianov, A., Langer, R., Roberts, B.E. Xenobiotic polymers as vaccine vehicles. Adv. Exp. Medi. Biol., 1995, 371(B):1475-1480.
8. Payne, L.G., Jenkins, S.A., Andrianov, A., Roberts, B.E. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery. Pharm. Biotechnol., 1995, 6:473-493.
9. Payne, L.G., Jenkins, S.A., Woods, A.L., Grund, E.M., Geribo, W.E., Loebelenz, J.R., Andrianov, A.K., Roberts, B.E. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine, 1998, 16(1):92-98.
10. Bouveret Le Cam, N.N., Ronco, J., Francon, A., Blondeau, C., Fanget, B. Adjuvants for influenza vaccine. Res. Immunol., 1998, 149(1):19-23.
11. Kim, J.H., Kirsch, E.A., Gilliam, B., Michael, N.L., VanCott, T.C., Ratto-Kim, S., Cox, J., Nielsen, R., Robb, M.L., Caudrelier, P., El Habib, R., McNeil, J. A phase I, open label, dose ranging trial of the Pasteur Merieux Connaught (PMC) oligomeric HIV-1 Gp160mn/LAI-2 vaccine in HIV seronegative adults. Abstracts of the 37th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, 1999.
12. Andrianov, A.K., Chen, J. Polyphosphazene microspheres: preparation by ionic complexation of phosphazene polyacids with spermine. J. Appl. Polym. Sci., 2006, 101(1):414-419.
13. Andrianov, A.K., Chen, J., Payne, L.G. Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions. Biomaterials, 1998, 19(1-3):109-115.
14. Goldberg, M., Langer, R., Jia, X. Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomater. Sci. Polym. Ed., 2007, 18(3): 241-268.
15. Lanza, R.P., Langer, R.S., Vacanti, J. Principles of Tissue Engineering. Academic Press, San Diego, CA, 2007.
16. Bano, M.C., Cohen, S., Visscher, K.B., Allcock, H.R., Langer, R. A novel synthetic method for hybridoma cell encapsulation. Nat. Biotechnol., 1991, 9(5): 468-471.
17. Bonzani, I.C., George, J.H., Stevens, M.M. Novel materials for bone and cartilage regeneration. Curr. Opini. Chemi. Biol., 2006, 10(6):568-575.
18. Cohen, S., Bano, M.C., Visscher, K.B., Chow, M., Allcock, H.R., Langer, R. Ionically crosslinkable polyphosphazene: a novel polymer for microencapsulation. J. Am. Chem. Soc., 1990, 112(21):7832-7833.
19. Andrianov, A.K., Marin, A., Peterson, P. Water-soluble biodegradable polyphosphazenes containing N-ethylpyrrolidone groups. Macromolecules, 2005, 38(19): 7972-7976.
20. Fee, C.J., Van Alstine, J.M. PEG-proteins: reaction engineering and separation issues. Chemi. Engi. Sci., 2006, 61(3):924-939.
21. Morar, A.S., Schrimsher, J.L., Chavez, M.D. PEGylation of proteins: a structural approach. Biopharm. Int., 2006, 19(4).
22. Veronese, F.M., Harris, J.M. Introduction and overview of peptide and protein pegylation. Adv. Drug Deliv. Rev., 2002, 54(4):453-456.
23. Veronese, F.M., Pasut, G. PEGylation, successful approach to drug delivery. Drug Discov. Today, 2005, 10(21):1451-1458.
24. Andrianov, A.K. Functionalized water-soluble polyphosphazene and uses thereof as modifiers of biological agents, WO2005099724, 2005.
25. Behl, M., Lendlein, A. Shape-memory polymers. Materi. Today, 2007, 10(4): 20-28.
26. Lendlein, A., Langer, R. Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296(5573):1673.
27. Sousa, J.E., Serruys, P.W., Costa, M.A. New frontiers in cardiology: drug-eluting stents: I. Circulation, 2003, 107(17):2274.
28. Kamath, K.R., Barry, J.J., Miller, K.M. The Taxust drug-eluting stent: a new paradigm in controlled drug delivery. Adv. Drug Deliv. Rev., 2006, 58(3): 412-436.
29. Zilberman, M., Eberhart, R.C. Drug-eluting bioresorbable stents for various applications. Annu. Rev. Biomed. Eng., 2006, 8:153-180.
30. Andrianov, A.K., Marin, A., Peterson, P., Chen, J. Fluorinated polyphosphazene polyelectrolytes. J. Appl. Polym. Sci., 2007, 103(1):53-58.
31. Allcock, H.R. Chemistry and Applications of Polyphosphazenes. Wiley, Hoboken, NJ, 2002. 725.
32. Andrianov, A.K., Chen, J., LeGolvan, M.P. Poly(dichlorophosphazene) as a precursor for biologically active polyphosphazenes: synthesis, characterization, and stabilization. Macromolecules, 2004, 37(2):414-420.
33. Andrianov, A.K. Water-soluble biodegradable polyphosphazenes:-emerging systems for biomedical applications. Polym. Prepri, 2005, 46(2):715.
34. Andrianov, A.K. Design and synthesis of functionalized polyphosphazenes with immune modulating activity. PMSE Prepr., 2003, 88.
35. Phase III Medical announces the successful creation of a core polymer library. Business Wire, May 13, 2004.
36. Andrianov, A.K., Marin, A., Chen, J., Sargent, J., Corbett, N. Novel route to sulfonated polyphosphazenes: single-step synthesis using ''noncovalent protection'' of sulfonic acid functionality. Macromolecules, 2004, 37(11):4075-4080.